Limocitrin increases cytotoxicity of KHYG-1 cells against K562 cells by modulating MAPK pathway

Natural killer (NK) cells are gaining popularity in the field of cancer immunotherapy. The present study was designed to investigate the effect of a natural flavonol compound limocitrin in increasing cytotoxicity of a permanent NK leukemia cell line KHYG-1 against an aggressive leukemia cell line K562. The findings revealed that limocitrin increased the expressions of cytolytic molecules perforin, granzymes A and B, and granulysin in KHYG-1 cells by inducing phosphorylation of transcription factor CREB, leading to increased lysis of K562 cells. Mechanistically, limocitrin was found to increase the expressions of t-Bid, cleaved caspase 3, and cleaved PARP to induce K562 cell apoptosis. Moreover, limocitrin reduced the expressions of SET and Ape1 to inhibit DNA repair mechanism, leading to caspase-independent K562 cell death. At the molecular level, limocitrin was found to increase the phosphorylation of ERK, p38, and JNK to increase granzyme B expression in KHYG-1 cells. Taken together, the study indicates that limocitrin increases cytotoxicity of NK cells against a range of cancer cells.

Automated summary

This study investigated the effect of limocitrin, a natural flavonol compound, on the cytotoxicity of NK cells against aggressive leukemia cells. Limocitrin increased the expressions of cytolytic molecules and induced cell apoptosis in leukemia cells. It also inhibited DNA repair mechanism and increased granzyme B expression in NK cells, ultimately enhancing the cytotoxicity of NK cells against cancer cells.